[1] B.C. Hancock, M. Parks, What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17(2000) 397-404.
[2] D. Mangin, F. Puel, S. Veesler, Polymorphism in processes of crystallization in solution:A practical review, Org. Process. Res. Dev. 13(2009) 1241-1253.
[3] T. Henriet, I. Gana, C. Ghaddar, M. Barrio, Y. Cartigny, N. Yagoubi, B. Do, J.-L. Tamarit, I.B. Rietveld, Solid state stability and solubility of triethylenetetramine dihydrochloride, Int. J. Pharm. 511(2016) 312-321.
[4] H. Al-Obaidi, M. Majumder, F. Bari, Amorphous and crystalline particulates:Challenges and perspectives in drug delivery, Curr. Pharm. Des. 23(2017) 350-361.
[5] A. Burger, R. Ramberger, On the polymorphism of pharmaceuticals and other molecular crystals. I, Microchim. Acta 72(1979) 259-271.
[6] L. Derdour, S. Pack, D. Skliar, C. Lai, S. Kiang, Crystallization from solutions containing multiple conformers:A new modeling approach for solubility and supersaturation, Chem. Eng. Sci. 66(2011) 88-102.
[7] J. Caplette, T. Frigo, M. Jozwiakowski, H. Shea, M. Mirmehrabi, P. Müller, Characterization of new crystalline forms of hydroxyprogesterone caproate, Int. J. Pharm. 527(2017) 42-51.
[8] A.R. Pallipurath, F. Civati, J. Sibik, C. Crowley, J.A. Zeitler, P. McArdle, A. Erxleben, A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations, Int. J. Pharm. 528(2017) 312-321.
[9] X. Xiong, K. Xu, S. Li, P. Tang, Y. Xiao, H. Li, Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form, Drug Dev. Ind. Pharm. 43(2017) 283-292.
[10] G. He, X. Chen, Y. Yin, W. Cai, W. Ke, Y. Kong, H. Zheng, Preparation and antibacterial properties of O-carboxymethyl chitosan/lincomycin hydrogels, J. Biomater. Sci. Polym. Ed. 27(2016) 370-384.
[11] A. Maher, D.M. Croker, Å.C. Rasmuson, B.K. Hodnett, Solution mediated polymorphic transformation:form Ⅱ to form Ⅲ piracetam in ethanol, Cryst. Growth Des. 12(2012) 6151-6157.
[12] S.A. Kulkarni, E. McGarrity, H. Meekes, J.H. ter Horst, Isonicotinamide selfassociation:The link between solvent and polymorph nucleation, Chem. Commun. 48(2012) 4983-4985.
[13] H. Kitano, T. Tanaka, I. Hirasawa, Study of polymorphic control in an ethanol-water binary solvent, J. Cryst. Growth 469(2017) 54-58.
[14] R. Paus, Y. Ji, Modeling and predicting the influence of variable factors on dissolution of crystalline pharmaceuticals, Chem. Eng. Sci. 145(2016) 10-20.
[15] M. Jim, K.-J. Kim, Solubility of forms I and Ⅱ of clopidogrel hydrogen sulfate in formic acid, N-Methylpyrrolidone, and N,N-dimethylformamide, J. Chem. Eng. Data 57(2012) 598-602.
[16] R. Bonfilio, J.S. Leal, O.M. Santos, G.R. Pereira, A.C. Doriguetto, M.B. de Araújo, Analysis of chlorthalidone polymorphs in raw materials and tablets and the effect of forms I and Ⅱ on the dissolution properties of drug products, J. Pharm. Biomed. Anal. 88(2014) 562-570.
[17] D. Hirai, Y. Iwao, S.-I. Kimura, S. Noguchi, S. Itai, Mathematical model to analyze the dissolution behavior of metastable crystals or amorphous drug accompanied with a solid-liquid interface reaction, Int. J. Pharm. 522(2017) 58-65.
[18] S. Katti, T. Seshadri, M. Viswamitra, Structure and conformation of didodium guanosine-5'-phosphate heptahydrate C10H13N5O8PNa2.7H2O, Curr. Sci. 49(1980) 533-535.
[19] S. Katti, T. Seshadri, M. Viswamitra, Structure of disodium guanosine 5'-phosphate heptahydrate, Acta Crystallogr. B Struct. Crystallogr. Cryst. Chem. 37(1981) 1825-1832.
[20] B.S. Liu, H. Sun, J.K. Wang, Q.X. Yin, Solubility of disodium 5'-guanylate heptahydrate in aqueous methanol mixtures, Food Chem. 128(2011) 218-221.
[21] R. Zhang, J. Ma, J. Li, Y. Jiang, M. Zheng, Effect of pH, temperature and solvent mole ratio on solubility of disodium 5'-guanylate in water + ethanol system, Fluid Phase Equilib. 303(2011) 35-39.
[22] F. Zou, W. Zhuang, J. Wu, J. Zhou, P. Yang, Q. Liu, Y. Chen, H. Ying, Determination of metastable zone widths and the primary nucleation and growth mechanisms for the crystallization of disodium guanosine 5'-monophosphate from a water-ethanol system, Ind. Eng. Chem. Res. 54(2015) 137-145.
[23] F. Zou, Q. Chen, P. Yang, J. Zhou, J. Wu, W. Zhuang, H. Ying, Solution-mediated polymorphic transformation:From amorphous to crystals of disodium guanosine 5'-monophosphate in ethanol, Ind. Eng. Chem. Res. 56(2017) 8274-8282.
[24] Y. Mo, L. Dang, H. Wei, Solubility of α-form and β-form of L-glutamic acid in different aqueous solvent mixtures, Fluid Phase Equilib. 300(2011) 105-109.
[25] F. Zou, W. Zhuang, J. Wu, J. Zhou, Q. Liu, Y. Chen, J. Xie, C. Zhu, T. Guo, H. Ying, Experimental measurement and modelling of solubility of inosine-5'-monophosphate disodium in pure and mixed solvents, J. Chem. Thermodyn. 77(2014) 14-22.
[26] F. Zou, W. Zhuang, Q. Chen, P. Yang, C. Lin, P. Jiao, J. Zhou, J. Wu, H. Ying, Solvent effects on nucleation of disodium guanosine 5'-monophosphate in anti-solvent/water mixtures, CrystEngComm 18(2016) 6653-6663.
[27] A.-T. Nguyen, J. Kang, W.-S. Kim, Noncommon ion effect on phase transformation of guanosine 5-monophosphate disodium in antisolvent crystallization, Ind. Eng. Chem. Res. 54(2015) 5784-5792.
[28] H. Kamio, H. Nakamachi, Water of crystallization in disodium 5'-inosinate and disodium 5'-guanylate and their mixed crystal formation, Yakugaku zasshi, J. Pharm. Soc. Jpn. 87(1967) 1436-1441.
[29] B. Li, Y. Wu, J. Zhu, K. Chen, B. Wu, L. Ji, Determination and correlation of solubility and mixing properties of isonicotinamide (form Ⅱ) in some pure solvents, Thermochim. Acta 627(2016) 55-60.
[30] Y. Liu, Z.-P. Zhao, J. Cui, G. Ren, Solubility of amorphous clopidogrel hydrogen sulfate in different pure solvents, J. Chem. Eng. Data 60(2015) 2442-2446.
[31] I. Montes, C.Q. Lai, D. Sanabria, Like dissolves like:A classroom demonstration and a guided-inquiry experiment for organic chemistry, J. Chem. Educ. 80(2003) 447-449.
[32] H. Tajmir Riahi, T. Theophanides, A Fourier transform infrared study of the electrophilic attack at the N7-site of guanosine-5'-monophosphate, Can. J. Chem. 62(1984) 266-272.
[33] J. Kang, N.A. Tuan, J.-M. Kim, S.-M. Chang, W.-S. Kim, Study of phase transformation of guanosine 5'-monophosphate in drowning-out crystallization, Appl. Biochem. Biotechnol. 160(2010) 561-573.
[34] A.-T. Nguyen, J. Kang, W.-S. Kim, Influence of salt additives on phase transformation of guanosine 5-monophosphate disodium in anti-solvent crystallization, J. Cryst. Growth 373(2013) 82-87.
[35] G. Kaptay, The Gibbs equation versus the kelvin and the Gibbs-Thomson equations to describe nucleation and equilibrium of nano-materials, J. Nanosci. Nanotechnol. 12(2012) 2625-2633.
[36] C.A. Hunter, J.F. McCabe, A. Spitaleri, Solvent effects of the structures of prenucleation aggregates of carbamazepine, Cryst. Eng. Comm. 14(2012) 7115-7117.
[37] K. Fucke, G.J. McIntyre, M.H. Lemée-Cailleau, C. Wilkinson, A.J. Edwards, J.A. Howard, J.W. Steed, Insights into the crystallisation process from anhydrous, hydrated and solvated crystal forms of diatrizoic acid, Chem. Eur. J. 21(2015) 1036-1047.
[38] L. Yang, Q. Yin, B. Hou, Y. Wang, Y. Bao, J. Wang, H. Hao, Solubility and thermodynamic stability of the enantiotropic polymorphs of 2, 3, 5-trimethyl-1, 4-diacetoxybenzene, Ind. Eng. Chem. Res. 52(2013) 2477-2485. |